SLC5A2 and diabetes mellitus: However, since this is a relatively short-term observation of a single case, it is necessary to accumulate more cases in the future to determine whether the combination of a DPP-4 inhibitor and an SGLT2 inhibitor is effective in the treatment of CMT complicated by diabetes mellitus.